236 related articles for article (PubMed ID: 32339904)
1. Generation of two LRRK2 homozygous knockout human induced pluripotent stem cell lines using CRISPR/Cas9.
Chen S; Luo Z; Ward C; Ibañez DP; Liu H; Zhong X; Sharma NK; Qin B; Fan W; Wang D
Stem Cell Res; 2020 May; 45():101804. PubMed ID: 32339904
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9 and piggyBac-mediated footprint-free LRRK2-G2019S knock-in reveals neuronal complexity phenotypes and α-Synuclein modulation in dopaminergic neurons.
Qing X; Walter J; Jarazo J; Arias-Fuenzalida J; Hillje AL; Schwamborn JC
Stem Cell Res; 2017 Oct; 24():44-50. PubMed ID: 28826027
[TBL] [Abstract][Full Text] [Related]
3. Generation of 2 induced pluripotent stem cell lines derived from patients with Parkinson's disease carrying LRRK2 G2385R variant.
Cheng YC; Huang CY; Ho MC; Hsu YH; Syu SH; Lu HE; Lin HI; Lin CH; Hsieh PCH
Stem Cell Res; 2018 Apr; 28():1-5. PubMed ID: 29414410
[TBL] [Abstract][Full Text] [Related]
4. In Vitro CRISPR/Cas9-Directed Gene Editing to Model LRRK2 G2019S Parkinson's Disease in Common Marmosets.
Vermilyea SC; Babinski A; Tran N; To S; Guthrie S; Kluss JH; Schmidt JK; Wiepz GJ; Meyer MG; Murphy ME; Cookson MR; Emborg ME; Golos TG
Sci Rep; 2020 Feb; 10(1):3447. PubMed ID: 32103062
[TBL] [Abstract][Full Text] [Related]
5. Generation of an induced pluripotent stem cell line (DANi-011A) from a Parkinson's disease patient with a LRRK2 p.G2019S mutation.
Chen M; Maimaitili M; Buchholdt SH; Jensen UB; Febbraro F; Denham M
Stem Cell Res; 2020 May; 45():101781. PubMed ID: 32305865
[TBL] [Abstract][Full Text] [Related]
6. Generation of gene-corrected iPSCs line (KEIUi001-A) from a PARK8 patient iPSCs with familial Parkinson's disease carrying the I2020T mutation in LRRK2.
Ohta E; Sone T; Ukai H; Hisamatsu T; Kitagawa T; Ishikawa M; Nagai M; Ueda HR; Obata F; Okano H
Stem Cell Res; 2020 Dec; 49():102073. PubMed ID: 33181472
[TBL] [Abstract][Full Text] [Related]
7. Generation of an induced pluripotent stem cell line (CSC-41) from a Parkinson's disease patient carrying a p.G2019S mutation in the LRRK2 gene.
Marote A; Pomeshchik Y; Collin A; Goldwurm S; Lamas NJ; Pinto L; Salgado AJ; Roybon L
Stem Cell Res; 2018 Apr; 28():44-47. PubMed ID: 29414418
[TBL] [Abstract][Full Text] [Related]
8. Generation of a human iPSC line (CIBi014-A) from a patient with Parkinson's disease carrying a novel heterozygotic PARK8 (LRRK2) mutation.
Li L; Si X; Yang J; Lei M; Liu H; Ruan J; Fu H; Li W; Yang H; Lei X; Sang H
Stem Cell Res; 2023 Feb; 66():102995. PubMed ID: 36528012
[TBL] [Abstract][Full Text] [Related]
9. Generation of induced pluripotent stem cells (NIMHi001-A) from a Parkinson's disease patient of East Indian ethnicity carrying LRRK2 I1371V variant.
Datta I; Sowmithra ; Jagtap S; Potdar C; Yadav R; Pal P
Stem Cell Res; 2020 Apr; 44():101768. PubMed ID: 32244201
[TBL] [Abstract][Full Text] [Related]
10. Generation and characterization of induced pluripotent stem cells from a Parkinson's disease patient carrying the digenic LRRK2 p.G2019S and GBA1 p.N409S mutations.
Oleksy C; Massart F; Goldwurm S; Arado A; Arena G; Boussaad I; Krüger R
Stem Cell Res; 2023 Oct; 72():103212. PubMed ID: 37832355
[TBL] [Abstract][Full Text] [Related]
11. In vitro genome editing rescues parkinsonism phenotypes in induced pluripotent stem cells-derived dopaminergic neurons carrying LRRK2 p.G2019S mutation.
Chang KH; Huang CY; Ou-Yang CH; Ho CH; Lin HY; Hsu CL; Chen YT; Chou YC; Chen YJ; Chen Y; Lin JL; Wang JK; Lin PW; Lin YR; Lin MH; Tseng CK; Lin CH
Stem Cell Res Ther; 2021 Sep; 12(1):508. PubMed ID: 34551822
[TBL] [Abstract][Full Text] [Related]
12. LRRK2 in peripheral and central nervous system innate immunity: its link to Parkinson's disease.
Lee H; James WS; Cowley SA
Biochem Soc Trans; 2017 Feb; 45(1):131-139. PubMed ID: 28202666
[TBL] [Abstract][Full Text] [Related]
13. Generation of induced pluripotent stem cells (IBMSi011-A) from a patient with Parkinson's disease carrying LRRK2 p.I1371V mutation.
Lin HI; Cheng YC; Ko HW; Wen CH; Lu HE; Huang CY; Hsieh PCH; Lin CH
Stem Cell Res; 2019 May; 37():101447. PubMed ID: 31029016
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic Analysis of the Results of Genome Editing on the Cell Model of Parkinson's Disease.
Vetchinova AS; Simonova VV; Novosadova EV; Manuilova ES; Nenasheva VV; Tarantul VZ; Grivennikov IA; Khaspekov LG; Illarioshkin SN
Bull Exp Biol Med; 2018 Jul; 165(3):378-381. PubMed ID: 30006877
[TBL] [Abstract][Full Text] [Related]
15. LRRK2 Expression Is Deregulated in Fibroblasts and Neurons from Parkinson Patients with Mutations in PINK1.
Azkona G; López de Maturana R; Del Rio P; Sousa A; Vazquez N; Zubiarrain A; Jimenez-Blasco D; Bolaños JP; Morales B; Auburger G; Arbelo JM; Sánchez-Pernaute R
Mol Neurobiol; 2018 Jan; 55(1):506-516. PubMed ID: 27975167
[TBL] [Abstract][Full Text] [Related]
16. Distinctive genomic signature of neural and intestinal organoids from familial Parkinson's disease patient-derived induced pluripotent stem cells.
Son MY; Sim H; Son YS; Jung KB; Lee MO; Oh JH; Chung SK; Jung CR; Kim J
Neuropathol Appl Neurobiol; 2017 Dec; 43(7):584-603. PubMed ID: 28235153
[TBL] [Abstract][Full Text] [Related]
17. Derivation, Characterization, and Neural Differentiation of Integration-Free Induced Pluripotent Stem Cell Lines from Parkinson's Disease Patients Carrying SNCA, LRRK2, PARK2, and GBA Mutations.
Momcilovic O; Sivapatham R; Oron TR; Meyer M; Mooney S; Rao MS; Zeng X
PLoS One; 2016; 11(5):e0154890. PubMed ID: 27191603
[TBL] [Abstract][Full Text] [Related]
18. Generation of homozygous PRKN, PINK1 and double PINK1/PRKN knockout cell lines from healthy induced pluripotent stem cells using CRISPR/Cas9 editing.
Chen CX; You Z; Abdian N; Sirois J; Shlaifer I; Tabatabaei M; Boivin MN; Gaborieau L; Karamchandani J; Beitel LK; Fon EA; Durcan TM
Stem Cell Res; 2022 Jul; 62():102806. PubMed ID: 35561458
[TBL] [Abstract][Full Text] [Related]
19. Generation of induced pluripotent stem cells from a patient with Parkinson's disease carrying LRRK2 p.I2012T mutation.
Lin CH; Cheng YC; Lin HI; Ho MC; Hsu YH; Wen CH; Ko HW; Lu HE; Huang CY; Hsieh PCH
Stem Cell Res; 2017 Dec; 25():123-127. PubMed ID: 29127874
[TBL] [Abstract][Full Text] [Related]
20. LRRK2 and the Immune System.
Dzamko NL
Adv Neurobiol; 2017; 14():123-143. PubMed ID: 28353282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]